DK0700395T3 - Indolderivater som steroid 5-alfa-reduktase-inhibitorer - Google Patents

Indolderivater som steroid 5-alfa-reduktase-inhibitorer

Info

Publication number
DK0700395T3
DK0700395T3 DK94917676.2T DK94917676T DK0700395T3 DK 0700395 T3 DK0700395 T3 DK 0700395T3 DK 94917676 T DK94917676 T DK 94917676T DK 0700395 T3 DK0700395 T3 DK 0700395T3
Authority
DK
Denmark
Prior art keywords
pct
steroid
reductase inhibitors
indole derivatives
alpha reductase
Prior art date
Application number
DK94917676.2T
Other languages
English (en)
Inventor
Julian Blagg
Graham Nigel Maw
David James Rawson
Original Assignee
Pfizer Ltd
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939311008A external-priority patent/GB9311008D0/en
Application filed by Pfizer Ltd, Pfizer Res & Dev filed Critical Pfizer Ltd
Application granted granted Critical
Publication of DK0700395T3 publication Critical patent/DK0700395T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK94917676.2T 1993-05-28 1994-05-26 Indolderivater som steroid 5-alfa-reduktase-inhibitorer DK0700395T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939311008A GB9311008D0 (en) 1993-05-28 1993-05-28 Indoles
GB939317529A GB9317529D0 (en) 1993-05-28 1993-08-20 Indoles

Publications (1)

Publication Number Publication Date
DK0700395T3 true DK0700395T3 (da) 1997-10-13

Family

ID=26302960

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94917676.2T DK0700395T3 (da) 1993-05-28 1994-05-26 Indolderivater som steroid 5-alfa-reduktase-inhibitorer

Country Status (14)

Country Link
US (2) US5696146A (da)
EP (1) EP0700395B1 (da)
JP (1) JP2757969B2 (da)
AT (1) ATE154352T1 (da)
AU (1) AU6930494A (da)
CA (1) CA2163778C (da)
DE (1) DE69403793T2 (da)
DK (1) DK0700395T3 (da)
ES (1) ES2102863T3 (da)
FI (1) FI113864B (da)
GR (1) GR3024366T3 (da)
HU (1) HU9501935D0 (da)
IL (1) IL109728A0 (da)
WO (1) WO1994027990A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9204365D0 (en) * 1992-02-28 1992-04-08 Pfizer Ltd Indoles
GB9317096D0 (en) * 1993-08-17 1993-09-29 Pfizer Ltd Indoles
RU2009116632A (ru) 2006-10-02 2010-11-10 Кортендо Инвест, Аб (Se) Энантиомер кетоконазола у людей

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9011335D0 (en) * 1990-05-21 1990-07-11 Fujisawa Pharmaceutical Co Indolebutyric acid derivatives and process for preparation thereof
GB9204365D0 (en) * 1992-02-28 1992-04-08 Pfizer Ltd Indoles
GB9317096D0 (en) * 1993-08-17 1993-09-29 Pfizer Ltd Indoles

Also Published As

Publication number Publication date
CA2163778A1 (en) 1994-12-08
AU6930494A (en) 1994-12-20
CA2163778C (en) 1999-04-27
EP0700395B1 (en) 1997-06-11
DE69403793D1 (de) 1997-07-17
FI955707A (fi) 1995-11-27
US5696146A (en) 1997-12-09
JP2757969B2 (ja) 1998-05-25
GR3024366T3 (en) 1997-11-28
IL109728A0 (en) 1994-08-26
FI113864B (fi) 2004-06-30
US5922747A (en) 1999-07-13
ATE154352T1 (de) 1997-06-15
EP0700395A1 (en) 1996-03-13
WO1994027990A1 (en) 1994-12-08
JPH08506350A (ja) 1996-07-09
FI955707A0 (fi) 1995-11-27
ES2102863T3 (es) 1997-08-01
DE69403793T2 (de) 1997-09-25
HU9501935D0 (en) 1995-09-28

Similar Documents

Publication Publication Date Title
DE69413542D1 (de) Perhydroisoindolderivate als substanz p antagonisten
DE60226469D1 (de) Biphenylkarbonsäureamidderivate als p38 kinase-inhibitoren
FI962155A (fi) Uudet 9-hydroksipyrido (1,2-a) pyrimidin-4-onieetterijohdannaiset
DK0677046T3 (da) Piperazinderivater som 5-HT-antagonister.
ATE233252T1 (de) Substituierte dihydrobenzofurane als pde- hemmstoffe
NO943187L (no) Indolderivater som steroid 5-alfa-reduktasehemmere
NO304227B1 (no) Substituerte imidazolderivater, preparat som inneholder disse og deres anvendelse
DK0700395T3 (da) Indolderivater som steroid 5-alfa-reduktase-inhibitorer
MX9303605A (es) Derivados de azabicicloheptano n-substituidas, su obtencion y uso.
DE69413831D1 (de) Phenoxyphenylcyclopentenyl-hydroxyharnstoffe
ATE163402T1 (de) Substituierte ortho- ethenylphenylessigsäurederivate
DE69405760D1 (de) 4-aza-pregnan-5-alpha-reductase isozym 1 inhibitoren
DK0687257T3 (da) 4-amino-2-(hetero)aryl-butanamider anvendelige som 5HT1A-antagonister
ES2164665T3 (es) Inhibidores de proteasas retrovirales.